Jobs / United States / Pfizer INC
Director, Applied AI (Horizon Scanning)
Pfizer INC · 🇺🇸 5 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Pfizer INC paid sponsored hires in similar roles1 certified filing for “Associate Director, Statistics Lead” (Statisticians) in VA: $135k–$135k, median $135k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
ROLE SUMMARY The Director, Applied AI (Horizon Scanning) is responsible for identifying, evaluating, and translating emerging AI technologies, capabilities, vendors, and industry trends into actionable opportunities for Pfizer’s U.S. Commercial organization. The role serves as the connection point between external AI innovation and U.S. Commercial strategy, ensuring that evolving technologies are assessed through the lens of commercial priorities, customer engagement, marketing, market access, patient solutions, commercial operations, and future business transformation. Reporting to the Senior Director, Strategy, this leader is responsible for horizon scanning, external technology intelligence, capability assessment, technology scouting, rapid evaluation, and future-state capability planning. The role helps ensure U.S. Commercial remains at the forefront of AI innovation while maintaining focus on business value, technical feasibility, enterprise readiness, and responsible adoption. The Director partners across AI Partnerships & Ecosystem, Product Management, AI Applications, Data Strategy, Transformation & Delivery, Governance, and Digital to convert external signals into a prioritized pipeline of opportunities, experiments, and roadmap recommendations. When an opportunity requires external engagement, the Director provides the technical and strategic assessment and transitions the opportunity to the AI Partnerships & Ecosystem Lead for partner engagement, coordination, and ongoing relationship management. WHY THIS ROLE MATTERS AI is evolving faster than traditional business and technology planning cycles. New foundation models, agent frameworks, industry-specific solutions, and commercial use cases emerge continuously. To maintain leadership in AI-enabled customer engagement and commercial operations, U.S. Commercial requires a dedicated capability focused on separating meaningful innovation from short-term hype, identifying strategic opportunities early, and determining where to invest, experiment, partner, incubate, or scale. This role ensures U.S. Commercial is not simply reacting to AI change but proactively shaping its future AI roadmap and external innovation agenda. ROLE RESPONSIBILITIES 1. U.S. Commercial AI Horizon Scanning • Continuously monitor emerging AI technologies, vendors, startups, research, industry developments, and competitive activity relevant to U.S. Commercial. • Track advances across generative AI, agentic systems, multimodal AI, intelligent automation, knowledge systems, customer engagement technology, commercial analytics, and AI infrastructure. • Maintain a structured horizon-scanning framework that categorizes developments by strategic relevance, maturity, feasibility, and potential business impact. • Produce concise executive updates on significant developments and their implications for U.S. Commercial. • Identify signals that should influence future Commercial Engine, product, architecture, and transformation roadmaps. 2. AI Innovation Assessment • Evaluate emerging AI technologies and capabilities against U.S. Commercial priorities. • Assess technical feasibility, scalability, differentiation, data requirements, integration considerations, and enterprise readiness. • Distinguish meaningful commercial opportunities from short-term market hype. • Create repeatable evaluation frameworks for AI products, vendors, models, platforms, and partnerships. • Recommend whether opportunities should be monitored, tested, partnered, incubated, scaled, or retired. 3. U.S. Commercial Opportunity Identification • Identify emerging AI capabilities that can create value across customer engagement, marketing, market access, patient solutions, insights and analytics, commercial operations, field enablement, and the